Christina Teeter Doligalski

Christina Teeter Doligalski

Auto-generated profile, based on publicly available information

Christina Teeter Doligalski

Department of Pharmacy UNC Health Chapel Hill North Carolina USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in Journal of Cystic Fibrosis
Verified
Journal Article
Closed access
CMCameron J. McKinzie
Cameron J. McKinzie
CDChristina T. Doligalski
Christina T. Doligalski
SLSteven J. Lobritto
Steven J. Lobritto
RCRaymond D. Coakley
Raymond D. Coakley
WGW. Adam Gower
W. Adam Gower

21 June 2022 in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Verified
Journal Article
Closed access
CDChristina Teeter Doligalski
Christina Teeter Doligalski
CMCameron J. McKinzie
Cameron J. McKinzie
AYAnita Yang
Anita Yang
LLL. Jason Lobo
L. Jason Lobo
RCRaymond Coakley
Raymond Coakley

4 May 2023 in American Journal of Transplantation
Verified
Journal Article
Open access
ALAlicia Beth Lichvar
Alicia Beth Lichvar
MCMary Moss Chandran
Mary Moss Chandran
ECElizabeth A. Cohen
Elizabeth A. Cohen
BCBarrett R. Crowther
Barrett R. Crowther
CDChristina Teeter Doligalski
Christina Teeter Doligalski
RARita R. Alloway
Rita R. Alloway
The role of the transplant pharmacist is recognized by transplant programs, governmental groups, and professional organizations as an essential part of the transplant multidisciplinary team. This role has evolved drastically over the last decade with the advent of major advances in the science of transplantation and the growth of the field, which necessitate expanded pharmacy services to meet the needs of patients. Data now exist within all realms of the phases of care for a transplant recipient regarding the utility and benefit of a solid organ transplant (SOT) pharmacist. Furthermore, governing bodies now have the opportunity to use Board Certification in Solid Organ Transplant Pharmacotherapy as a mechanism to identify and recognize specialty knowledge and expertise within the field of SOT pharmacotherapy. The purpose of this paper is to provide an overarching review of the current and future state of SOT pharmacy while also identifying major changes to the profession, forthcoming challenges, and expected areas of growth.

28 August 2016 in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Verified
Journal Article
Closed access
PDF file
JCJillian P. Casale
Jillian P. Casale
CDChristina T. Doligalski
Christina T. Doligalski

17 May 2023 in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Verified
Journal Article
Open access
HKHeather L. Kutzler
Heather L. Kutzler
ALAlicia B. Lichvar
Alicia B. Lichvar
DQDavid Quan
David Quan
LBLyndsey J. Bowman
Lyndsey J. Bowman
ADAdam Diamond
Adam Diamond
JFJames Fleming
James Fleming
The opioid epidemic has impacted analgesia in the postoperative period for solid organ transplant (SOT) donors and recipients. However, optimal pain management and opioid stewardship strategies have not been identified across this unique population. The purpose of this systematic review was to evaluate the impact of perioperative opioid use and to describe multimodal analgesic strategies to reduce opiate use in SOT recipients and living donors. A systematic review was conducted. Electronic searches were performed in Medline, Embase, Google Scholar, and Web of Science through December 31, 2021. Title and abstracts were screened. Relevant articles underwent full‐text review. Literature was separated into effects of opioid exposure on post‐transplant outcomes, recipient pain management strategies, and living donor pain management strategies. Search yielded 25,190 records, and 63 were ultimately included. The impact of opioid use on post‐transplant outcomes was assessed in 19 publications. The risk of graft loss in pretransplant opioid users was assessed in six reports and was found to be higher in the majority (66%) of publications. Opioid minimization strategies were reported in 20 studies in transplant recipients. Twenty‐four studies evaluated pain management strategies in living donors. Both populations used a combination of multimodal strategies to minimize opioid use throughout the hospitalization and on discharge. Opioids are associated with select negative outcomes in post‐transplant recipients. To minimize their use while also maintaining appropriate analgesia, multimodal pain regimens should be considered in SOT recipients and donors.

5 December 2020 in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Verified
Journal Article
Closed access
PDF file
IHIan B. Hollis
Ian B. Hollis
CDChristina T. Doligalski
Christina T. Doligalski
DJDouglas J. Jennings
Douglas J. Jennings